SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-07-000427
Filing Date
2007-02-13
Accepted
2007-02-13 17:29:20
Documents
1
Group Members
DEERFIELD CAPITAL, L.P.DEERFIELD INTERNATIONAL LIMITEDDEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITEDDEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G e601596_sc13ga-parpharm.txt SC 13G/A 32130
  Complete submission text file 0001193805-07-000427.txt   34400
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Subject) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-46121 | Film No.: 07611836
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 212-551-1600
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A